SAN DIEGO, Sept. 28, 2023 Turnstone Biologics Corp. , a clinical-stage biotechnology company developing new medicines to treat and cure solid tumors by pioneering a differentiated approach to.
Published: Apr 13, 2021
MENLO PARK, Calif. and BOSTON, April 13, 2021 (GLOBE NEWSWIRE)
Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced the appointment of Blake Aftab, Ph.D., as Vice President of Research. Dr. Aftab will lead Adicet’s research group and will further develop existing and new opportunities for the Company’s gamma delta T cell platform.
“We are very excited to have Blake join Adicet, and lead our research team as we advance the clinical development of ADI-001 and rapidly develop a deep pipeline of “off-the-shelf” gamma delta T cell therapies,” said Stewart Abbot, Chief Scientific and Operating Officer of Adicet. “Blake has committed his career, with notable success, to researching and developing cell therapies across a variety of indications including oncology, infectious disease, and autoimmune conditions, while also buildin
Adicet Bio Appoints Dr Blake Aftab as Vice President of Research streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.